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Abstract
Enterohemorrhagic Escherichia coli (EHEC) are food-borne pathogens that can cause serious infections ranging from
diarrhea to hemorrhagic colitis (HC) and hemolytic-uremic syndrome (HUS). Translocation of Shiga-toxins (Stx) from the gut
lumen to underlying tissues is a decisive step in the development of the infection, but the mechanisms involved remain
unclear. Many bacterial pathogens target the follicle-associated epithelium, which overlies Peyer’s patches (PPs), cross the
intestinal barrier through M cells and are captured by mucosal macrophages. Here, translocation across M cells, as well as
survival and proliferation of EHEC strains within THP-1 macrophages were investigated using EHEC O157:H7 reference
strains, isogenic mutants, and 15 EHEC strains isolated from HC/HUS patients. We showed for the first time that E. coli
O157:H7 strains are able to interact in vivo with murine PPs, to translocate ex vivo through murine ileal mucosa with PPs and
across an in vitro human M cell model. EHEC strains are also able to survive and to produce Stx in macrophages, which
induce cell apoptosis and Stx release. In conclusion, our results suggest that the uptake of EHEC by M cells and underlying
macrophages in the PP may be a critical step in Stx translocation and release in vivo. A new model for EHEC infection in
humans is proposed that could help in a fuller understanding of EHEC-associated diseases.
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Introduction
Enterohemorrhagic Escherichia coli (EHEC), a subset of Shiga
toxin-producing E. coli (STEC), have been associated with human
diseases, ranging from uncomplicated diarrhea to hemorrhagic
colitis (HC) and hemolytic-uremic syndrome (HUS). A recent
major outbreak in Germany, with thousands cases of foodborne
illness (and approximately 25% of them progressing to HUS) has
shed light on EHEC [1,2]. The gastrointestinal tract of cattle and
other ruminants appears to be the main reservoir of STEC strains
[3,4]. Several studies have reported a high prevalence of STEC
belonging to a wide range of serotypes in animals and food
products [3,4,5]. However, only a limited number of serotypes
have been associated with human disease, among which O157:H7
is predominant [3,6]. The association of serotypes with disease of
varying severity in humans and with outbreaks or sporadic disease
has led to the proposal that STEC be classified into 5
seropathotypes, from A (most virulent) to E (serotypes that have
not been involved in disease in humans) [7].
EHEC colonize the digestive tract of humans and produce
Shiga toxins (Stx1 and/or Stx2), also known as Verotoxins, which
are essential for virulence. Epidemiological studies, together with
in vitro and in vivo experiments, have shown that Stx2 is the most
common virulence factor associated with severe human disease
[3]. Stx are composed of an enzymatically active A subunit and a
pentameric B subunit. The B subunits form a doughnut-shaped
structure with a central pore and bind to the glycosphingolipid
globotriaosylceramide (Gb3, also known as CD77), which is
expressed at the surface of endothelial cells, leading to subsequent
internalization of the toxin [8]. The A subunit is able to inhibit
elongation of the peptide chain during protein synthesis, resulting
in eukaryotic cell death, tissue damage and organ failure [3,8].
EHEC, together with enteropathogenic E. coli (EPEC), belong to
the attaching and effacing (A/E) bacterial pathogens. They induce
histopathological lesions characterized by localized effacement of
the brush border microvilli and intimate attachment of the
bacteria to the apical membrane of epithelial cells, through the
formation of cytoskeletal actin pedestals [9,10]. All the genes
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involved in A/E lesions map to a pathogenicity island, the Locus
for Enterocyte Effacement (LEE) that encodes a type III secretion
system (TTSS) involved in the injection of several proteins and
effectors [11]. The first gene associated with A/E lesions is the eae
gene encoding intimin, an outer membrane protein. Intimin
binding to Tir, a receptor translocated from the bacteria to the
host cell, mediates intimate adherence of the bacterium to
epithelial cells. Several intimin types have been identified that
may determine the host tropism [12]. Many other factors have
been suggested to be associated with EHEC virulence. These
include enterohemolysin, a pore-forming cytolysin, an extracellu-
lar serine-protease, and a catalase-peroxidase [3,13]. Flagella are
also thought to play a role in adherence to epithelial cells. H7
flagella have been shown to act as an adhesin to bovine intestinal
epithelium [14] and H7 flagellin (encoded by the fliC gene)
induced proinflammatory signals in human colon epithelial cells
through activation of the MAP kinase and NF-kB pathways [15].
Experiments using in vitro organ culture (IVOC) of human
intestinal mucosa revealed a preferential tropism of EHEC
O157:H7 for the follicle-associated epithelium (FAE) overlying
the distal ileal Peyer’s patches (PPs), where it causes A/E lesions
[12,16,17]. The FAE is characterized by the presence of
specialized ‘‘membranous’’ or ‘‘microfold’’ cells (M cells), which
are specialized in the translocation of microorganisms and
antigens from the intestinal lumen to the basolateral side of the
epithelium, where they are delivered to the underlying macro-
phages [18,19]. While M cells are primarly involved in sampling
intestinal antigens, many invasive Enterobacteriaceae, such as
Salmonella enterica serovar Typhimurium [20], rabbit enteroadher-
ent E. coli [21] or Adherent-Invasive E. coli (AIEC) isolated from
patients with Crohn’s disease [22,23], take advantage of the
transcytotic characteristics of M cells to use them as an entry site to
translocate across the intestinal barrier.
Systemic complications associated with EHEC diseases such as
HUS require the expression and translocation of Stx, which are
produced by colonizing bacteria, from the gut lumen to underlying
tissues and the bloodstream. However, the mechanism of Stx
translocation across the epithelial barrier remains unclear as
human intestinal cells lack Gb3, the Stx receptor. Since EHEC
O157:H7 was found to interact initially with FAE in both humans
and cattle [12,16,24], we hypothesized that the uptake of bacteria
by M cells and underlying macrophages may be the first stage in
Stx translocation, and may represent an important step in the
pathogenesis of EHEC infections. We report here the interactions
of EHEC strains in vivo and ex vivo with murine PPs, and in vitro
using a human M cell model. Binding to the FAE and
translocation through M cells may result in the rapid contact of
bacteria with underlying human macrophages. However, little
information is known about the interactions between EHEC
strains and these cells. We decided, therefore, to investigate entry,
survival and proliferation of EHEC strains belonging to sero-
pathotypes A to C in human THP-1 macrophages. EHEC were
found to survive and to produce Stx within macrophages, leading
to host cell apoptosis and Stx release.
Materials and Methods
Bacterial strains
Bacterial strains and plasmids used in this study are given in
Table 1. The green fluorescent protein (GFP)-expressing strains
were obtained by electroporation of a high-copy plasmid
pFPV25.1. Before use, each strain was streaked onto LB agar
plates (BD Bioscience, USA) and grown overnight at 37uC in LB
broth, unless otherwise stated. When necessary, kanamycin or
ampicillin was added to the medium at 50 mg/ml. For ex vivo
experiments, a non pathogenic E. coli strain MG1655 (RifR) was
used and plated on LB medium containing rifampicin (300 mg/
ml).
Ethics statement
Animal protocols were approved by the committee for ethical
issues, CEMEA Auvergne (Agreement to Nicolas Barnich,
CEMEA CE16-09, Clermont-Ferrand, France). Mice were killed
by cervical dislocation according to animal care procedure.
Ex vivo interactions with murine Peyer’s patches
Eight- to ten-week old FVB/N wild-type male mice were bread
and reared in the animal care facility at the Universite´ d’Auvergne
(Clermont-Ferrand, France) under specific pathogen free (SPF)
conditions.
Biopsies from ileum with or without PP were immediately
removed from mouse intestine and used for Ussing chamber
experiments. Briefly, 1 cm of ileal samples was opened along the
mesenteric border, splatted and mounted in an Ussing chamber
with an opening area of 0.96 mm2. Tissues were bathed in 37uC-
oxygenated Ringer solution for 5 h. A total of 1.6 ml of 16
107 CFU/ml (colony forming units) of EHEC or non pathogenic E.
coli was added to the mucosal compartment and 1.6 ml of Ringer
buffer was placed into the serosal side. To quantify the bacteria
translocated across mucosa, medium from the serosal compartment
was collected every hour, diluted, and plated onto LB agar plates.
The integrity of ileal mucosa was monitored throughout Ussing
chamber experiments using Fluorescein isothiocyanate (FITC)
(Sigma, St. Louis, MO). FITC diffusion was assessed by fluorescence
measurement in a microplate fluorescent reader (Fluoroskan Ascent
FL, Thermo) at an excitation wavelength of 485 nm and an
emission wavelength of 522 nm.
Mice ileal loop assay
Interactions of EHEC bacteria with PPs were studied using
mouse ileal loops, as previously described by Hitotsubashi et al. [25].
FVB/N wild-type male mice were starved for 24 h before operation
but provided with water ad libitum. The animals were anesthetized
and their intestine exteriorized through a midline incision. Two or
three intestinal segments (about 1 cm), each containing one PP,
were ligated, and 56108 CFU of bacteria (EHEC 86-24 WT and
86-24 Dstx2, a non-pathogenic E. coli strain K-12 C600, and a
control AIEC strain LF82) were injected into the ileal loop. Two
hours after injection, the animals were killed and the loops were
excised. To find a colocalization of 86-24WT bacteria with M cells,
4 mm sections of paraffin-embedded PPs were stained with
Tetramethyl Rhodamine Isocyanate (TRITC)-labeled Ulex europaeus
agglutinin 1 (UEA 1, Sigma-Aldrich, France) to label M cells.
Hoechst was used for nuclear staining and a monoclonal mouse
antibody raised against E. coli LPS O157 (Abcam, France) was used
to label EHEC bacteria. The slides were then analyzed with a Zeiss
LSM 510 Meta confocal microscope.
Cell lines and cell culture
The in vitro M cell co-culture model was first developped by
Kerneis et al. and later adapted by Gullberg et al. [26,27]. The
human colorectal adenocarcinoma cell-line Caco-2 clone 1 [27]
was grown in complete DMEM (PAA, Austria), supplemented
with 10% heat-inactivated fetal bovine serum (FBS) (Lonza,
Switzerland), 4 mM L-glutamine (PAA), 100 U/ml penicillin
(PAA) and 100 mg/ml streptomycin (PAA). The human Burkitt’s
lymphoma cell-line Raji B (ECACC 85011429) was grown in
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complete RPMI-1640 medium (PAA), supplemented with 10%
heat-inactivated FBS, 8 mM L-glutamine, 100 U/ml penicillin
and 100 mg/ml streptomycin.
The human (macrophage-like) monocyte cell line THP-1
(ATCC TIB202) was maintained in RPMI-1640 medium
supplemented with 10% heat-inactivated FBS and 4 mM L-
glutamine. THP-1 cells were activated using 20 ng/ml phorbol
12-myristate 13-acetate (PMA) (Sigma-Aldrich), seeded in 24-well
tissue culture plates (BD Falcon, USA) at a density of 56105 cells
per cm2, and grown for 18 h.
Vero cells (African green monkey kidney cells, ATCC CRL
1587) were grown at 37uC in Eagle basal medium (Seromed,
Table 1. Bacterial strains and plasmid used in this study.
Strains or
plasmids Serotype Seropathotype Characteristics stx genotype
Source or
reference
Strains
86-24 WT O157:H7 A Enterohemorragic E. coli O157:H7
reference strain
stx12 stx2+ [44]
86-24 Dstx2 O157:H7 NA 86-24 isogenic mutant with stx2
gene deleted
stx12 stx22 [15]
86-24 Deae O157:H7 NA 86-24 isogenic mutant with eae
gene deleted
stx12 stx2+ [15]
86-24 DfliC O157:H7 NA 86-24 isogenic mutant with fliC
gene deleted
stx12 stx2+ [15]
EDL933 O157:H7 A Enterohemorragic E. coli O157:H7
reference strain
stx1+ stx2+ ATCC 43895
CHVi-1 O157:H7 A E. coli isolated from a clinical case
with HUS
stx12 stx2+ [13]
CH1898 O157:H7 A E. coli isolated from a clinical case
with HUS
stx12 stx2+ [13]
CH075 O157:H7 A E. coli isolated from a clinical case
with HUS
stx12 stx2+ [13]
CH087 O103:H2 B E. coli isolated from a clinical case
with HUS
stx1+ stx22 [13]
CH089 O103:H2 B E. coli isolated from a clinical case
with HC
stx1+ stx22 [13]
NV-10 O26:H11 B E. coli isolated from a clinical case
with diarrhea
stx1+ stx22 [4]
CH071 O157:H26 C E. coli isolated from a clinical case
with HUS
stx12 stx2+ [13]
CH013 O91:H10 C E. coli isolated from a clinical case
with HUS
stx12 stx2+ [13]
CH085 O91:H10 C E. coli isolated from a clinical case
with HUS
stx12 stx2+ [13]
CH014 O91:H21 C E. coli isolated from a clinical case
with HUS
stx12 stx2+ [13]
VTH13 O91:H21 C E. coli isolated from a clinical case
with HC
stx1+ stx2+ Blanco Ja
CH016 O174:H2 C E. coli isolated from a clinical case
with HUS
stx12 stx2+ [13]
CH123 O5:H2 ND E. coli isolated from a clinical case
with HC
stx1+ stx22 [13]
CH017 O+:H2 ND E. coli isolated from a clinical case
with HUS
stx12 stx2+ [13]
CH023 O+:H2 ND E. coli isolated from a clinical case
with HUS
stx12 stx2+ [13]
LF82 O83:H1 NA Adherent-Invasive E. coli isolated
from a patient with Crohn’s disease
NA [45]
MG1655 OR:H48/K2 NA Non pathogenic E. coli NA Laboratory stock
C600 K-12 NA Non pathogenic E. coli NA Laboratory stock
Plasmid
pFPV25.1 Plasmid constitutively expressing
GFP
[46]
NA, not applicable; ND, not determined; HUS, Hemolytic-uremic syndrome; HC, Hemorrhagic colitis; WT, wild-type.
aLaboratorio de Referencia de E. coli, Universidade de Santiago de Compostela, Lugo, Spain.
doi:10.1371/journal.pone.0023594.t001
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Germany) supplemented with 10% FBS, 8 mM l-glutamine,
100 U/ml penicillin,100 mg/ml streptomycin and 1% vitamin
solution, and seeded in 96-well tissue culture plates at a density of
106 cells per ml.
All the cell lines were grown at 37uC under 5% CO2 in a
humidified atmosphere.
Vero toxin assay
To quantify Stx production, bacterial culture supernatants and
infected THP-1 supernatants were tested for cytotoxicity in the
Vero cell assay, as previously described [4]. THP-1 cells were
infected for 2 h, extra-cellular bacteria were removed and fresh
medium was added for 3 h, before testing Stx in supernatants. The
Stx titre was expressed as the reciprocal of the highest filtrate
dilution that caused 50% cell detachment after 24 h of incubation,
as judged by the dye intensity and by microscopic observation (the
breakpoint for a positive result was a titer of 4). Known
concentrations of purified Stx2 (Toxin Technology, USA) were
used to estimate the range of Stx2 release within macrophages.
Each experiment was performed at least 3 times.
Bacterial translocation across M cells
A total of 16106 Caco-2-cl1 cells per ml were seeded onto the
apical aspect of TranswellTM filters (Millipore Ltd, UK) previously
Figure 1. Ex vivo transmucosal uptake of EHEC bacteria by murine Peyer’s patches, and in vivo interactions with murine M cells in
ileal loop assays. (A) Ex vivo interaction of E. coli O157:H7 (strain 86-24 WT) with murine mucosa isolated from the ileum with (n= 10) or without
(n= 7) Peyer’s patches (PPs) in Ussing chambers. Each point represents the number of translocated bacteria (CFU/mm2) for one experiment at the
time of infection (0 h) and after 3 h, 4 h and 5 h of contact. Lines represent the median values of the group. Comparisons were made with the Mann-
Whitney test. *, Ileum with PP significantly different from ileal mucosa (P,0.05). (B) Ex vivo interaction of non pathogenic E. coli MG1655 with murine
ileal mucosa isolated from the ileum with (n= 5) or without (n= 6) PPs in Ussing chambers. Each point represents the number of translocated bacteria
(CFU/mm2) for one experiment at the time of infection (0 h) and after 3 h, 4 h and 5 h of contact. (C) Macroscopic analysis of murine PP sections after
a two-hour contact with EHEC 86-24 WT, 86-24 Dstx2, AIEC strain LF82 and non pathogenic E. coli K-12 strain C600 in ileal loop assays. Dashed circles
indicate PP. Scale bar = 1 mm. (D) Confocal analysis of murine PP sections after labeling of EHEC 86-24 WT with anti LPS O157 antibody (green), of M
cell with UEA-1 TRITC (red) and DNA with Hoechst (blue). Scale bar = 20 mm. Arrowheads, bacteria associated with UEA-1-positive cells.
doi:10.1371/journal.pone.0023594.g001
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coated with BD MatrigelTM (USA). Cells were carefully cultured
for 17 days until they reached a fully differentiated phenotype.
56105 Raji-B cells were added to the basolateral compartment of
Caco-2 monolayers and co-culture was maintained for 4–6 days.
Monocultures of Caco-2 cells on matched filter supports were used
as control.
For translocation assay, apical surface of M-cells were infected
with 16107 bacteria per transwell. Samples from basolateral
media were collected every hour for 5 h, and 10-fold dilutions
were plated onto LB agar. The integrity of cell monolayers was
tested by monitoring trans-epithelial electrical resistance (TEER)
with a MillicellH-ERS (Millipore).
Figure 2. In vitro translocation of EHEC strains across human M cell monolayers. The number of translocated bacteria (CFU/ml) at 1 to 5 h
post infection was determined in M cell monolayers versus control Caco-2 monolayers, for EHEC 86-24 Dstx2 (O157:H7) (A) and compared with 86-24
WT and 86-24 Deae (B) and with EDL 933 (O157:H7) and CH087 (O103:H2) (C). Results are means 6 standard error of mean (SEM) for replicate
experiments. Translocation through M cell monolayers significantly different from that of Caco-2 monolayers (* P,0.05 or ** P,0.01).
doi:10.1371/journal.pone.0023594.g002
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Bacterial uptake, survival and replication in human
macrophages
Bacterial uptake, survival and replication were measured by the
gentamicin protection assay. Bacterial strains were grown for 2 h
at 37uC in LB. Before infection, cell monolayers were washed
twice with PBS and the medium was replaced with 1 ml of RPMI-
1640 supplemented with 10% heat-inactivated FBS for 2 h. THP-
1 cells were infected with a multiplicity of infection (MOI) of 10
bacteria per macrophage. After a 2-h incubation, infected
macrophages were washed twice with PBS, and fresh cell culture
medium containing 20 mg/ml of gentamicin was added to kill
extracellular bacteria. After incubation for 1, 4, 24 or 48 h, the
medium was removed, cells were washed once with PBS, and a
5 min treatment with 500 ml 1X-triton was used to lyse the
eukaryotic cells. This concentration of Triton X-100 had no effect
on bacterial viability for at least 30 min. Samples were collected,
diluted, and plated onto Mueller-Hinton agar plates to determine
the number of bacteria surviving gentamicin killing assay. Survival
was expressed either as CFU/well or as the mean percentage of
the number of bacteria recovered at 4, 24 and 48 h post-infection,
compared to that at 1 h post-infection, defined as 100%. Each
experiment was performed at least five times.
Lactate dehydrogenase activity (LDH)
Supernatants of infected macrophages were sampled at 1, 4, 8
and 24 h of gentamicin treatment, and assayed for LDH activity
using reduced nicotinamide adenine dinucleotide (NAD) as a
substrate (LDH kit, Boehringer Mannheim, France).
Hoechst Staining of THP-1 macrophages
Coverslips with adherent infected THP-1 cells were collected at
specified time points, fixed with 4% paraformaldehyde, washed
twice with PBS, and stained with Hoechst (5 mg/ml) for 30 min at
room temperature. Coverslips were washed three times with
saponin, twice with PBS, and mounted on glass slides. Apoptotic
nuclei were quantified by fluorescence microscopy. Each exper-
iment was performed four times. Five random fields were counted
on each slide.
Transmission electron microscopy (TEM)
Cross sections of THP-1 cells were prepared as follows. After
infection, cells were fixed with 3% glutaraldehyde in 0.2 M
cacodylate buffer at 4uC for 2 h and post fixed in 1% OsO4 in
cacodylate buffer at 4uC for 1 h. After dehydratation in ethanol,
cultures were embedded in a 2-mm-thick Epon coating and
polymerized for 3 days at 60uC. Suitable areas were oriented
parallel to the cell layer surface on Epon blocks with an Epon
mixture. Ultrathin sections were contrasted with uranyl acetate
and lead citrate. Grids were examined with Hitachi H7650 TEM.
Confocal microscopy of infected THP-1 macrophages
After infection with GFP-expressing bacteria, as described
above, THP-1 cells were washed with PBS to eliminate extra-
cellular bacteria and fixed with 3% paraformaldehyde for 10 min.
Fixed-cells were washed with PBS, incubated for 5 min with
0.1 M glycine, washed with PBS, and permeabilized with 0.1%
Triton X-100 for 20 min. After PBS-washing, slides were
incubated twice for 10 min, each time with PBS–0.2% gelatin.
Actin cytoskeleton was stained for 15 min using TRITC-
phalloidin (Sigma-Aldrich, France). Monolayers were then washed
with PBS and distilled water, stained with 49,6-diamidino-2-
phenylindole (DAPI) and mounted on glass slides with a Mowiol
solution (Calbiochem, Darmstadt, Germany). The slides were
examined with a Zeiss LSM 510 Meta confocal microscope.
Statistical analysis
The Student t-test was used for unpaired data with a 5% level of
significance for the comparison of values. For Ussing chamber
experiments, comparisons were made with the unpaired Mann
Whitney test.
Results
EHEC strains interact ex vivo with murine Peyer’s patches
and in vivo with murine M cells
EHEC mucosal translocation across murine ileal mucosa was
studied in Ussing chambers. Transmucosal uptake of EHEC 86-24
Figure 3. Survival and replication of EHEC strains within human THP-1 macrophages at 24 h post-infection. Results are expressed as
the number of intracellular bacteria at 24 h relative to that obtained at 1 h after gentamicin exposure, taken as 100%. A, seropathotype A; B,
seropathotype B; C, seropathotype C; ND, seropathotype not determined. All assays were performed independently at least five times. Results are
means 6 Standard Deviation (SD) for the replicate experiments.
doi:10.1371/journal.pone.0023594.g003
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WT bacteria through murine ileal mucosa without PP was very
low, even after 5 h of infection (Figure 1A). In contrast, bacterial
translocation was observed for ileal biopsies containing PP,
reaching a median number of translocating bacteria of
1.16105 CFU/mm2 at 5 h, versus no translocating bacteria for
6 out of 7 ileal mucosa without PP (P,0.05) (Figure 1A). As a
control, a non pathogenic E. coli strain was not able to translocate
across ileal mucosa either with or without PP (Figure 1B). The
integrity of ileal mucosa was monitored throughout Ussing
chamber experiments: FITC diffusion was limited and there was
no difference between Stx-producing bacteria and non pathogenic
E. coli (Figure S1). To confirm ex vivo data, in vivo experiments using
mouse ileal loop containing one PP were performed. Interestingly,
bloodshot PPs were observed macroscopically in ileal mucosa after
a two-hour contact with wild type EHEC. This was not the case
with a Stx-negative E. coli strain 86-24 Dstx2, nor with the AIEC
strain LF82, an invasive E. coli pathovar known to target PPs, nor
with a non pathogenic E. coli strain K-12 C600 (Figure 1C).
Confocal analysis revealed that 86-24 WT EHEC bacteria interact
with murine M cells (Figure 1D).
EHEC strains are able to translocate across M cells
Since 86-24 WT EHEC interact in vivo with murine M cells, we
used an in vitro model in which human intestinal epithelial cells
acquire M cell-like characteristics after being co-cultured with Raji
B cells to study bacterial translocation. Experiments were first
Figure 4. Entry and survival of EHEC strains within THP-1 macrophages. Percentage of intracellular bacteria at 1 h relative to 86-24 WT
taken as 100% (A), and percentage of intracellular bacteria at 24 h/1 h and 48 h/1 h post-infection (B) for EHEC 86-24 WT, and 86-24 Dstx2, 86-24
Deae, and 86-24 DfliC isogenic mutants. All assays were performed independently at least four times. Results are means 6 SD for the replicate
experiments. Panel A) * 86-24 DfliC significantly different from 86-24 WT (P,0.05). Panel B) * 86-24 Dstx2 significantly different from 86-24 WT at 24 h
post-infection (P,0.05).
doi:10.1371/journal.pone.0023594.g004
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performed using an E. coli 86-24 Dstx2 mutant to avoid possible cell
death induced by Stx. Translocation of E. coli 86-24 Dstx2
remained at low levels with the control Caco-2 monolayer [27]
(4.66106616106 CFU/ml), but increased with time in the in vitro
M cell model, reaching 5.1610761.76107 CFU/ml at 5 h post
infection (P,0.01) (Figure 2A). The behavior of 86-24 WT and
86-24 Deae mutant was then analyzed and was similar to that of
86-24 Dstx2 (Figure 2B), indicating that (i) Stx does not interfere
with the co-culture model and (ii) intimin (product of the eae gene)
is not directly involved in translocation in this model. An
additional O157:H7 reference strain (EDL933) and a non-O157
EHEC of serotype O103:H2 (CH087) were also able to translocate
across M cells (Figure 2C), supporting the hypothesis that this
mechanism could be extended to all EHEC strains. In contrast,
the non pathogenic E. coli strain K-12 C600 was not able to
translocate at levels similar to that of EHEC strains, since only
7.46104 CFU/ml were recovered after a 5 h contact with M cells.
The translocation of EHEC bacteria was not the result of a loss of
the monolayer integrity, since TEER stayed constant during the
5 h of infection (Figure S2).
EHEC strains can replicate within THP-1 macrophages
The study was performed with 15 EHEC strains isolated from
HC/HUS patients and two O157:H7 reference strains (86-24 WT
and EDL933). Bacterial uptake, survival and replication in THP-1
cells were measured by the gentamicin protection assay. The non
pathogenic E. coli strain K-12 C600 was used as a negative control
and AIEC strain LF82 (isolated from a patient with Crohn’s
disease and able to highly replicate within macrophages) as a
positive control [28,29]. The number of intracellular bacteria was
determined 1 h, 24 h and 48 h post-infection in the presence of
gentamicin. The ability of EHEC strains to enter macrophages
varied widely from one strain to another. The amount of
intracellular bacteria at 1 h post-infection ranged from
1.76104 CFU/well for CH016, to 5.86105 CFU/well for
CH015 (data not shown). The ability to enter macrophages was
not related to serotype or belonging to a seropathotype.
Survival or replication of EHEC strains at 24 h post-infection was
expressed as a percentage compared to the number of bacteria at
1 h, defined as 100%. The nonpathogenic E. coliK-12 C600 control
strain was slowly but efficiently killed following phagocytosis by
THP-1 cells: only 7% of the bacteria initially internalized were
recovered at 24 h post-infection, evidence of the bactericidal activity
of the THP-1 macrophages (Figure 3). All EHEC strains were able
to survive within macrophages after 24 h. Compared to those of the
negative control (E. coli K-12 C600), the percentages of survival
were higher, ranging from 23% for CHVi-1 to 155% for CH071.
However, in contrast with what was observed for the positive
control (AIEC strain LF82), the number of intracellular bacteria at
24 h post-infection was smaller than at 1 h post-infection (less than
100%) in all but two strains (CH013 and CH071). No link was
found between the ability of strains to survive/replicate and their
serotype. After investigating the ability of strains to express Stx, we
observed that the strains able to replicate within macrophages no
longer expressed Stx (Stx titers,4, see Figure 3).
To confirm that Stx play a role in the ability of EHEC strains to
survive and/or replicate within macrophages, stx isogenic mutants
of the O157:H7 reference strains 86-24 WT and EDL933 were
used. For 86-24 WT, the number of bacteria internalized after 1 h,
defined as 100%, was 2.16105 CFU/well (Figure 4A), and the
survival rate was 51%, indicating that the level of intracellular
bacteria was two-fold lower after 24 h than after 1 h (Figure 4B).
The entry of the 86-24 Dstx2 mutant was slightly less than that of
the wild type (81%, Figure 4A), but the percentage of survival was
186% (Figure 4B), indicating that the number of intracellular
bacteria had almost doubled compared to time 1 h. The behavior
of the isogenic Deae mutant did not differ from that of the 86-24
WT strain. Interestingly, the percentage of survival at 48 h post-
infection was low for all the strains tested, around 5% for Stx-
producing strains and 35% for Dstx2 mutants and non-Stx-
producing bacteria. Identical results were obtained with EDL933
and its isogenic Dstx and Deae mutants (data not shown).
Cytotoxic effects of EHEC infection on THP-1
macrophages
To check if EHEC were able to produce Stx within
macrophages, supernatants of infected THP-1 cells were tested
using a Vero toxin assay. High amounts of Stx were recovered
from THP-1 macrophages infected with EHEC 86-24 WT and
EDL933: the cytotoxic titer was 1/256 (1/28) and the average
amount of toxin was estimated to be 8.261.8 ng/ml. As expected,
no cytotoxic effect was observed in the supernatants of THP-1
infected with a non pathogenic E. coli strain or the 86-24 Dstx2
mutant (Table 2).
Culture supernatants of infected macrophages were assayed for
the presence of the cytoplasmic LDH to estimate the membrane
integrity of the cells and the cytotoxic effect of EHEC strains. The
amounts of LDH released were expressed as LDH activity
recovered in the supernatant relative to LDH activity of total cell
lysis defined as 100%. Infection of THP-1 cells with wild type 86-
24 EHEC strain resulted in high release of LDH, which reached
20% at 24 h post-infection (Figure 5A). In contrast, the amounts of
LDH released from Dstx2-infected macrophages were significantly
lower than those of cells infected with the 86-24 WT strain
(P,0.05). Since Stx have been shown to induce apoptosis in
epithelial, endothelial and monocytic cells [30,31], we decided to
perform fluorescence microscopy analysis of THP-1 nucleus
stained with Hoechst. Unlike the 86-24 Dstx2 mutant, macro-
phages infected with 86-24 WT for 24 h had fragmented nuclei,
characteristic of apoptotic cells (Figure 5B). Quantifications of
apoptotic cells are shown in Figure 5C. After a 4-h to 24-h
infection, 86-24 WT increased the percentage of apoptotic cells,
compared with cells infected with the Dstx2 mutant or non infected
(NI) cells (P,0.05). At 24 h, the percentage of apoptotic cells
reached 5% of the remaining cells, compared to 0.3% and 0.1%
with the Dstx2 mutant and non infected cells, respectively
(P,0.05).
Morphological data to confirm the cytotoxic effects and survival
of EHEC wild type strain and the Dstx2 mutant within THP-1 cells
were obtained with confocal microscopy and TEM. One hour
Table 2. Quantification of Stx released after THP-1 infections.
Strains Cytotoxic titera
Stx concentrationb
(ng/ml)
86-24 WT 1/256 8.261.8
86-24 Dstx2 - 0
86-24 Deae - 0
EDL933 1/256 8.261.8
K-12 C600 - 0
aThe verotoxin titer was expressed as the reciprocal of the highest sample
dilution which caused 50% cell detachment after 24 h of incubation.
bStx concentration in the supernatant of infected THP-1 macrophages.
The results of 3 independent sets of data are presented.
-, no cytotoxic effect.
doi:10.1371/journal.pone.0023594.t002
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after infection, whatever the strain, many macrophages were
infected with only a few bacteria present in small vacuoles
(Figure 6A and C). At 24 h post-infection with 86-24 WT, cell
layers were damaged and very few bacteria were found within
macrophages (Figure 6D), suggesting that Stx production had
driven the cells to apoptosis and release of intracellular bacteria
Figure 5. Induction of apoptosis in THP-1 macrophages infected by EHEC strains. Percentage of lactate dehydrogenase (LDH) activity at
1 h, 4 h, and 24 h post-infection (A). Fluorescence microscopy analysis of 86-24 WT and 86-24 Dstx2 infected THP-1 macrophages stained with
Hoechst at 24 h post-infection. Arrowheads indicate the fragmented nuclei of apoptotic cells (B). Quantification of apoptosis in infected THP-1
stained with Hoechst (C). Results are expressed as percentage of apoptotic cells numbered by microscopy observation. Results are mean 6 SEM of
four independent experiments. NI, non infected. Panel A) * 86-24 Dstx2 significantly different from 86-24 WT at 24 h (P,0.05). Panel C) 86-24 Dstx2
and NI significantly different from 86-24 WT at 4 h and 24 h (*) (P,0.05).
doi:10.1371/journal.pone.0023594.g005
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into the antibiotic containing media. In contrast, THP-1
macrophages infected with the 86-24 Dstx2 mutant contained
many bacterial clusters (Figure 6B and E), indicating that non-Stx-
producing bacteria were able to replicate within macrophages; no
morphological evidence of cytotoxicity was observed, confirming
LDH release results.
Discussion
EHEC O157:H7 are one of the most common pathogens
involved in large outbreaks of severe gastrointestinal illnesses
around the world [2,6]. EHEC are implicated in a wide spectrum
of clinical outcomes ranging from nonbloody diarrhea to HC and
HUS. Stx, one of the major virulence factors produced by EHEC,
plays an important role in the development of complications such
as HUS [3]. To cause human illness, orally ingested EHEC must
survive the acidic environment of the stomach [3]. However,
recent studies evaluating the survival of an E. coli O157:H7 strain
in a simulated in vitro model of human digestive tract, revealed a
bacterial mortality in the stomach and duodenum. A bacterial
growth was observed in the distal parts of the small intestine,
suggesting that high levels of bacteria could be present in the ileum
and in the colon [32]. EHEC are thought to colonize the colonic
mucosa but do not invade deeper layers of the mucosa or spread
systemically. Studies conducted using human intestinal IVOC
have revealed a preferential tropism of EHEC for the FAE
overlying ileal PPs, which is associated with a lack of colonic
adhesion [12,16,17]. EHEC can induce A/E lesions on IVOC
prepared from bovine ileum [16], but the principal site of
colonization of EHEC O157:H7 is the lymphoid follicle-dense
mucosa at the terminal rectum in the bovine host [24]. If EHEC
target FAE, we hypothesized that the uptake of bacteria by M cells
and underlying macrophages, which is observed for some
pathogenic bacteria, may be the first step in EHEC translocation
and subsequent toxin transport across the intestinal barrier.
It is now well documented that invasive members of the
Enterobacteriaceae family, such as Salmonella, Shigella or AIEC, use M
cells as the initial point of interaction with the host mucosa
[18,20,22,23,33]. M cells transcytosis has been studied in vitro using
a procedure to differentiate human intestinal epithelial cells (Caco-
2) into M cells by co-culture with Raji B lymphocytes. This model
exhibits morphological and functional characteristics of M cells,
such as loss of microvilli, downregulation of brush-border enzy-
mes, upregulation of particle transport, and enhanced transloca-
tion of pathogens [26,27]. Salmonella translocation across this co-
culture model was greater than in Caco-2 control monolayers,
while translocation of EPEC, Listeria monocytogenes or Clostridium
difficile was not enhanced in M cells compared to Caco-2 [18,34].
We show here for the first time that EHEC strains, including
O157:H7 and non-O157 serotypes, are able to significantly
translocate through M cell monolayers compared to Caco-2
monolayers. A non pathogenic E. coli strain was not able to
translocate at levels similar to that of EHEC strains. The high level
of EHEC translocation through M cells is not a result of the loss of
monolayer integrity, since the transepithelial electrical resistance of
M cell monolayers was not modified after infection neither with
EHEC strains 86-24 WT and EDL 933, nor with a non
pathogenic E. coli. The Ussing chamber system is also a useful
model of ex vivo intact organ culture to study mechanisms of
bacterial translocation and the pathogenesis of enteric infections.
Figure 6. Survival and cytotoxic effects of EHEC strains within THP-1 macrophages. Confocal microscopy (A and B) and Transmission
Electron Microscopy (TEM) (C, D, and E) analysis of THP-1 macrophages infected with EHEC strains. THP-1 macrophages were infected with the 86-24
WT strain (A, C and D) and with the 86-24 Dstx2 isogenic mutant (B and E) at 1 h post-infection (A and C) and at 24 h post-infection (B, D and E). For
confocal micrographs, THP-1 macrophages were infected with GFP-positive 86-24 WT and 86-24 Dstx2 isogenic mutant (green color). The actin
cytoskeleton of cells was stained with TRITC phalloidin (red), and DNA was stained with DAPI (blue). Arrowheads indicate bacteria within THP-1
macrophages. Scale bar = 10 mm (A and B). Scale bar = 1 mm (C, D and E).
doi:10.1371/journal.pone.0023594.g006
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Transmucosal uptake of EHEC strain 86-24 WT was confirmed
and we observed high levels of bacterial translocation through
murine ileal mucosa containing PP, whereas very few bacteria
crossed the ileal mucosa in the absence of PP. In vivo ileal loop
assays confirmed a specific targeting of EHEC to FAE overlying
PP regions. Taken together, our in vitro, ex vivo and in vivo
Figure 7. New working model for EHEC infection in humans. The diagram shows a monolayer of intestinal epithelial cells with EHEC infection
in the lumen. Stx production occurs in the intestine. The bacteria cross the intestinal barrier through M cells. In the lamina propria, bacteria enter,
survive, and produce Stx within resident macrophages. Following replication of bacteria in macrophages, extensive Stx production induces host cell
death. Subsequently, released Stx could cross the downstream blood vessels to reach the kidneys, intestine, and brain. Damage to these organs
results in serious life-threatening complications in humans.
doi:10.1371/journal.pone.0023594.g007
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experiments demonstrate that EHEC strains target M cells on the
surface of PPs in order to translocate across the epithelial barrier.
Moreover, we describe for the first time that a two-hour contact
with wild type EHEC induces hemorrhagic lesions in PPs in ileal
loop assays, whereas such phenomenon is not found for AIEC
strain LF82, an invasive E. coli pathovar known to target PPs [23].
A Stx-negative mutant is not able to induce bloodshot in ileal loop,
which confirms the well known role of Stx in hemorrhagic lesions.
The molecular mechanisms that mediate the transport of bacteria
across M cells remain unclear, and the bacterial effectors involved
have not yet been totally identified. Intimin types might play a role in
determining the pattern of colonisation and tissue tropism in the host,
and intimin c appears to restrict colonization of O157:H7 strains to
human FAE [16]. Moreover, intimin c binds b1-integrins, which are
expressed on the apical surface of M cells [35]. Contrary to
expectations, deletion of the eae gene in strain 86-24 did not alter
translocation rates in our M cell model (Figure 2B) whereas the
mutant was impaired in its capacity to adhere to epithelial intestinal
cells (data not shown). Our results indicate that the LEE encoded
genes may not promote translocation across M cells in EHEC. The
long polar fimbriae (LPF), encoded by the lpf operon, play a key role
in Salmonella enterica serovar Typhimurium [36] and in AIEC [23] to
mediate bacterial interactions with M cells. The lpf operon was
detected in an O91:H21 HUS associated strain, using a genomic
subtractive hybridization procedure to identify virulence DNA
sequences [37], and the complete genome sequence of O157:H7
strains revealed the presence of two lpf operons [38,39]. Their
expression is tightly regulated, and LPF were reported to be
associated with adherence in EHEC O157:H7 to cultured epithelial
cells [40]. However, deletion of one or both of the lpf operons in
O157:H7 did not reduce FAE adhesion but enhanced colonization to
small intestine, suggesting that LPF do not promote the targeting of
PP in EHEC O157:H7 [41].
The enteric pathogens crossing the FAE are captured by
resident macrophages and subepithelial dendritic cells in the dome
of the lymphoid follicle [19]. In this study, we analyzed the entry,
survival and proliferation of 17 EHEC strains and isogenic
mutants in human THP-1 macrophages. We showed that EHEC
were able to survive within macrophages for 24 h and to produce
Stx, thereby inducing cell apoptosis of THP-1 macrophages and
toxin release. Studies using human epithelial, endothelial and
monocytic cell lines have shown that purified Stx induce apoptotic
cell death in vitro [31]. The mechanism of Stx-induced apoptosis in
the human myeloid leukaemia cell line THP-1 involves the
increased expression of DR5 and TRAIL and activation of
caspase-8 via a calpain-dependent mechanism through endoplas-
mic reticulum stress response [30,31]. Furthermore, Stx encoding
genes were seen to be up-regulated in intracellular bacteria [42].
Stx1 and Stx2 are able to cross polarized intestinal epithelial
cells via a transcellular process and to remain biologically active
after translocation, and it was shown that neutrophil transmigra-
tion enhanced the translocation of Stx, probably by opening a
non-specific paracellular pathway across a polarized monolayer of
T84 epithelial cells [43]. Here we propose an alternative pathway
for Stx translocation via bacterial uptake by M cells and underlying
macrophages. After bacterial uptake by M cells, Stx induce
apoptosis in underlying infected macrophages, which leads to
EHEC and toxin release in the lamina propria. In our experimental
conditions, the average survival rate for the 86-24 wild type strain
was only 51% because bacteria released into the antibiotic
containing media were killed. In contrast in vivo, EHEC strains
could be released in the lamina propria. We found that EHEC were
able to replicate within THP-1 macrophages after 24 h but were
killed after 48 h, unlike AIEC LF82 strain, which was still able to
replicate within macrophages [28,29]. More and more bacterial
pathogens are observed to be able to translocate across the FAE via
M cells, but their fate varies greatly depending on the pathogen.
Salmonella, which are able to survive within macrophage, can
spread throughout the organism, leading to bacteraemia and to
systemic diseases. In contrast, infections due to Shigella or AIEC are
restricted to the digestive tract. In vivo, EHEC could be eventually
killed and therefore would not invade deeper layers of the mucosa,
but the toxins released could gain access to the systemic circu-
lation. The amount of toxin that translocates across intestinal
epithelia is probably one of the most important factors in
determining the development of systemic complications.
As observed with Shigella, the infectious dose for E. coli O157:H7
estimated from outbreak data is considered to be as low as 1 to 100
organisms [3]. The targeting of bacteria to M cells and subsequent
capture by macrophages could explain why only a small amount of
bacteria would be sufficient to trigger disease, which determines, in
part, the efficiency of the infection and the low infectious dose. We
propose a new model for EHEC infection in humans (Figure 7)
and suggest that bacteria cross the intestinal barrier through M
cells overlying PPs. In the lamina propria, bacteria could enter,
survive, and produce Stx within resident macrophages, inducing
host cell apoptosis. In this case, however, bacteria would be
eventually killed without causing bacteraemia. Subsequently,
released Stx would cross the downstream blood vessels to reach
the kidneys, intestine, and brain leading to severe disease in
humans. The study of the relationships between interactions with
M cells and the development of disease could help in designing
novel therapeutic approaches to EHEC infection.
Supporting Information
Figure S1 Integrity of murine ileal mucosa determined
by monitoring of FITC diffusion. The mucosal integrity was
monitored ex vivo in Ussing chambers by following FITC diffusion
after infection with EHEC strain 86-24 WT and non pathogenic E.
coli strain MG1655. Murine mucosa was isolated from the ileum,
with Peyer’s Patches (PP) (86-24WT& andMG1655% ) or without
PP (86-24WTN andMG1655#) placed inUssing chambers during
a 5-hour contact. One representative set of data is presented.
(TIF)
Figure S2 Integrity of cell monolayers determined by
trans-epithelial resistance (TEER) measurement. TEER
was monitored during a 5-hour infection in Caco-2 (A) and M cell
monolayers (B), infected with EHEC strains 86-24 WT (Caco-2 m
and M cells n), and EDL 933 (Caco-2 N and M cells#) or with a
non pathogenic E. coli K-12 C600 (Caco-2 & and M cells e).
(TIF)
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